✦ LIBER ✦

Mechanism of blood-borne metastases. I. Some factors affecting lodgment and growth of tumor cells in the lungs

✍ Scribed by Akihiko Koike

Publisher: John Wiley and Sons
Year: 1964
Tongue: English
Weight: 945 KB
Volume: 17
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196404)17:4<450::aid-cncr2820170406>3.0.co;2-2

No coin nor oath required. For personal study only.

✦ Synopsis

This investigation was aided by a grant (P-312) from ,the American Cancer Society, Inc.

The author is grateful to Dr. George E. Moore for his advice throughout the study and for his criticism in the preparation of the manuscript.

📜 SIMILAR VOLUMES

Experimental studies of factors influenc

Experimental studies of factors influencing hepatic metastases. I. The effect of number of tumor cells injected and time of growth

✍ Edwin R. Fisher; Bernard Fisher 📂 Article 📅 1959 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

Purification and characterization of a M

Purification and characterization of a Mr ∼66,000 lung-derived (paracrine) growth factor that preferentially stimulates the in vitro proliferation of lung-metastasizing tumor cells

✍ Philip G. Cavanaugh; Garth L. Nicolson 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 967 KB

In medium containing low concentrations of serum, rat 13762NF mammary adenocarcinoma cell lines and clones (MTPa and MTC; isolated from the locally growing tumor) of low metastatic potential to lung did not exhibit a growth response to lung-conditioned medium, whereas a highly metastatic cell clone

Response to dual blockade of epidermal g

Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor

✍ Shirish M. Gadgeel; Shadan Ali; Philip A. Philip; Fakhara Ahmed; Antoinette Wozn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) have demonstrated clinical benefit in patients with nonsmall cell lung cancer (NSCLC), particularly those with tumors that have EGFR‐TK domain mutations. Moreover, the EGFR and cyclooxygenase (COX)‐2

Bombesin/gastrin-releasing peptide antag

Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma

✍ Miklós Koppán; Gábor Halmos; José M. Arencibia; Najib Lamharzi; Andrew V. Schall 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## BACKGROUND. Antagonists of bombesin/gastrin-releasing peptide (BN/GRP) have been developed to block the autocrine stimulatory effect of BN/GRP on tumors such as small cell lung carcinoma (SCLC). Although several studies have addressed the intracellular events that follow the formation of the re